Abstracts tagged "Environmental factors and familial Mediterranean fever"

Abstract Number: 2032 • 2012 ACR/ARHP Annual Meeting
Results From a Multicentre International Registry of Familial Mediterranean Fever: Impact of Genetic and Environment Factors On the Expression of a Monogenic Disease in Children
Seza Ozen¹, Erkan Demirkaya², Gayane Amaryan³, Isabelle Koné-Paut³, Adem Polat³, Turker Turker³, Patricia Woo⁴, Yosef Uziel⁵, Consuelo Modesto³, Martina Finetti³, Pierre Quartier⁶, Efimia Papadopoulou-Alataki³, Sulaiman Al-Mayouf³, Giovanna Fabio³, Romina Gallizzi⁷, Luca Cantarini⁸, Joost Frenkel⁹, Susan Nielsen¹⁰, Michael Hofer³, Antonella Insalaco³, Huri Ozdogan³, Nicolino Ruperto³ and Marco Gattorno³, ¹Hacettepe University, Ankara, Turkey, ²Gulhane Military Medical Faculty, Ankara, Turkey, ³Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, ⁴University College London, London, United Kingdom, ⁵Pediatric Rheumatology, Meir medical center, Kfar Saba, Israel, ⁶Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, ⁷University of Messina, Messina, Italy, ⁸University of Siena, Siena, Italy, ⁹University Medical Center Utrecht, Utrecht, Netherlands, ¹⁰Istituto Giannina Gaslini, Genoa, Italy
Background/Purpose: Familial Mediterranean Fever (FMF) is an autoinflammatory disease caused by mutations in a single gene, the MEFV gene. The disease is very frequent among…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].